Listen in as rheumatology experts Alexis Ogdie, MD, MSCE, and Julia Swafford, PA-C, DFAAPA, discuss emerging therapies and strategies in managing patients with axial spondyloarthritis or psoriatic arthritis, including:

• The current treatment landscape (eg, small molecules, biologics)
• Risk factors to consider when prescribing JAK inhibitors
• Key considerations regarding comorbidities, especially in addressing depression, anxiety, or social ideation 
• Nonpharmacologic options to improve treatment outcomes
• Shared decision-making strategies to enhance patients’ investment in their care

Presenter:

Alexis Ogdie, MD, MSCE
Director, Penn Psoriatic Arthritis and Spondylarthritis Program
Director, Penn Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania
Philadelphia, Pennsylvania

Julia Swafford, PA-C, DFAAPA
President of SPAR
Bronson Battle Creek Rheumatology Specialists
Battle Creek, Michigan

Link to full program: 
bit.ly/4gkTzSv